Sales & Marketing News | pharmaphorum

News

Pharma furious as UK Statutory Scheme rebate rate soars

The UK pharma sector has reacted with consternation to the government's proposal to raise the Statutory Scheme rate to 32.2% in the last half of 2025.

News

Rumour confirmed as Mallinckrodt merges with Endo

Two pharmas that filed for bankruptcy protection due to opioid litigation in the US – Mallinckrodt and Endo – are rumoured to be in merger talks.

News

Kelun-Biotech first to bag TROP2 approval in lung cancer

Kelun-Biotech wins first global regulatory approval - in China - for a TROP2-directed antibody-drug conjugate (ADC) in lung cancer.

News

Olivér Várhelyi, EU Commissioner for Health and Animal Welfare

EU proposes legislation to bolster medicines supply chain

The EU has proposed legislation to safeguard the supply of critical medicines but pharma and patient groups are concerned about the details.

News

Merck MS tablet set for wider use by NHS in England

Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad.

News

man in protective gear at manufacturing facility

MSD opens $1bn plant for HPV vaccine in the US

MSD has opened the doors of a $1bn facility at its site in Durham, North Carolina, that will be used to produce its HPV vaccine Gardasil.

Pharma furious as UK Statutory Scheme rebate rate soars

Rumour confirmed as Mallinckrodt merges with Endo

Kelun-Biotech first to bag TROP2 approval in lung cancer

EU proposes legislation to bolster medicines supply chain

Merck MS tablet set for wider use by NHS in England

MSD opens $1bn plant for HPV vaccine in the US

AZ grabs FDA nod for Ultomiris in rare kidney disease IgAN

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks